Swiss National Bank’s Dr. Reddy's Laboratories RDY Stock Holding History

Swiss National Bank’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-708,795	Closed	-$5.31M	–	2523
2019 Q2	$5.31M	Buy	708,795 +187,985	+36%	+$1.48M	0.01%	1082
2019 Q1	$4.14M	Hold	520,810	–	–	﹤0.01%	1203
2018 Q4	$3.93M	Hold	520,810	–	–	0.01%	1126
2018 Q3	$3.6M	Hold	520,810	–	–	﹤0.01%	1336
2018 Q2	$3.35M	Hold	520,810	–	–	﹤0.01%	1370
2018 Q1	$3.4M	Hold	520,810	–	–	﹤0.01%	1291
2017 Q4	$3.91M	Hold	520,810	–	–	﹤0.01%	1219
2017 Q3	$3.72M	Hold	520,810	–	–	﹤0.01%	1206
2017 Q2	$4.39M	Hold	520,810	–	–	0.01%	1078
2017 Q1	$4.18M	Hold	520,810	–	–	0.01%	1087
2016 Q4	$4.72M	Hold	520,810	–	–	0.01%	983
2016 Q3	$4.82M	Sell	520,810 -310,510	-37%	-$2.96M	0.01%	929
2016 Q2	$8.52M	Hold	831,320	–	–	0.01%	681
2016 Q1	$7.51M	Hold	831,320	–	–	0.01%	704
2015 Q4	$7.7M	Hold	831,320	–	–	0.02%	642
2015 Q3	$10.6M	Hold	831,320	–	–	0.03%	549
2015 Q2	$9.2M	Hold	831,320	–	–	0.02%	584
2015 Q1	$9.49M	Buy	+831,320	New	+$8.82M	0.03%	571

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Swiss National Bank's RDY Position: Q3 2019 in Review

Swiss National Bank sold out of Dr. Reddy's Laboratories (RDY) in Q3 2019, closing a stake of 708,795 shares — an estimated $5.31M sold.

Swiss National Bank first reported a position in RDY in Q1 2015 and held it in 18 quarters. The position peaked at $10.6M in Q3 2015. 152 funds tracked by Wall St. Rank hold RDY as of Q3 2019.

Swiss National Bank reported no remaining Dr. Reddy's Laboratories position as of Q3 2019 after selling out during the quarter.
Swiss National Bank sold 708,795 Dr. Reddy's Laboratories shares in Q3 2019, an estimated $5.31M.
Swiss National Bank first reported a position in Dr. Reddy's Laboratories in Q1 2015 and held it in 18 quarters.
Swiss National Bank's Dr. Reddy's Laboratories position peaked at $10.6M in Q3 2015.
152 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2019.

Based on Swiss National Bank's 13F filing for Q3 2019, filed 12 Nov 2019.